Analyzing Numinus Wellness (OTCMKTS:NUMIF) and Joint (NASDAQ:JYNT)

Numinus Wellness (OTCMKTS:NUMIF) and Joint (NASDAQ:JYNT) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Insider & Institutional Ownership

76.9% of Joint shares are owned by institutional investors. 30.2% of Joint shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Numinus Wellness and Joint, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Numinus Wellness	0	0	0	0	N/A
Joint	0	0	2	0	3.00

Joint has a consensus target price of $18.00, indicating a potential upside of 60.00%. Given Joint’s higher possible upside, analysts plainly believe Joint is more favorable than Numinus Wellness.

Profitability

This table compares Numinus Wellness and Joint’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Numinus Wellness	N/A	N/A	N/A
Joint	-12.00%	2.17%	0.67%

Earnings & Valuation

This table compares Numinus Wellness and Joint”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Numinus Wellness	N/A	N/A	N/A	N/A	N/A
Joint	$120.07 million	1.40	-$9.75 million	($0.75)	-15.00

Numinus Wellness has higher earnings, but lower revenue than Joint.

Summary

Joint beats Numinus Wellness on 7 of the 8 factors compared between the two stocks.

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.